Skip to search.
 FTSE 100 Up 0.62%
Streaming
Ticker Tape: On

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
2.31 Down 0.05(2.12%) 17 Apr 21:00
Add to Portfolio
Prev Close:2.36
Open:2.35
Bid:2.28 x 500
Ask:3.60 x 2000
1y Target Est:7.50
Beta:-0.002
Next Earnings Date:N/A
Day's Range:2.24 - 2.41
52wk Range:2.09 - 6.64
Volume:96,216
Avg Vol (3m):372,985
Market Cap:76.19m
P/E (ttm):N/A
EPS (ttm):-1.73
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KBIODown 2.12%76.19m
VRTXDown 0.34%15.13b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,768.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.54
Quarterly EPS Est (Mar-14) :-0.38
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, primarily develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback